Shawn Vadala Sells 1,895 Shares of Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International, Inc. (NYSE:MTD) CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,696,789.76. This trade represents a 26.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shawn Vadala also recently made the following trade(s):

• On Tuesday, August 19th, Shawn Vadala sold 300 shares of Mettler-Toledo International stock. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00.

Mettler-Toledo International Trading Down 0.6%

MTD stock opened at $1,404.27 on Friday. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,471.06. The company has a market capitalization of $28.69 billion, a P/E ratio of 35.56, a PEG ratio of 4.19 and a beta of 1.41. The firm has a 50 day simple moving average of $1,334.60 and a 200-day simple moving average of $1,248.36.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in Mettler-Toledo International by 1.3% in the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock valued at $3,180,950,000 after buying an additional 34,466 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after acquiring an additional 376,419 shares during the period. Capital International Investors lifted its position in Mettler-Toledo International by 1.2% in the 3rd quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock valued at $1,055,203,000 after purchasing an additional 10,395 shares during the last quarter. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 1.1% during the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock valued at $842,802,000 after purchasing an additional 8,121 shares during the period. Finally, Geode Capital Management LLC grew its position in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after purchasing an additional 3,383 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on MTD. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. raised their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Finally, Barclays boosted their target price on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research note on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $1,406.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.